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ABSTRACT Gaining insights into the dynamic processes of molecular interactions that mediate cell-substrate and cell-cell
adhesion is of great signiﬁcance in the understanding of numerous physiological processes driven by intercellular communication.
Here, an acoustic-wave biosensor is used to study and characterize speciﬁc interactions between cell-bound membrane proteins
and surface-immobilized ligands, using as a model system the binding of major histocompatibility complex class I HLA-A2 proteins
to anti-HLA-A2 monoclonal antibodies. The energy of the acoustic signal, measured as amplitude change, was found to depend
directly on the number of HLA-A2/antibody complexes formed on the device surface. Real-time acoustic data were used to monitor
the surface binding of cell suspensions at a range of 6.0 3 104 to 6.0 3 105 cells mL1. Membrane interactions are governed by
two-dimensional chemistry because of the molecules’ conﬁnement to the lipid bilayer. The two-dimensional kinetics and afﬁnity
constant of the HLA-A2/antibody interaction were calculated (ka ¼ 1.15 3 105 mm2 s1 per molecule, kd ¼ 2.07 3 105 s1,
and KA ¼ 0.556 mm2 per molecule, at 25C), based on a detailed acoustic data analysis. Results indicate that acoustic biosensors
can emerge as a signiﬁcant tool for probing and characterizing cell-membrane interactions in the immune system, and for fast and
label-free screening of membrane molecules using whole cells.
INTRODUCTION
Membrane proteins have great biological and biotechnologi-
cal signiﬁcance. They comprise;30%of all proteins encoded
by the genome, and they mediate interactions of cells with
extracellular components or other cells. They also comprise
the target for the majority of drugs on the market. Under in
vivo conditions, cells are in constant communication with
their environment via molecules anchored to or embedded in
the cell membrane. The binding of cell-membrane molecules
to speciﬁc ligands that are also attached to another (cell)
surface is pivotal in numerous physiological and develop-
mental conditions, such as leukocyte adhesion and rolling
(1–4) and cell-mediated immune reactions (5–7). Surface
interactions involving cell-bound membrane proteins are
physically distinct from the binding interactions that occur
when soluble molecules are used, because membrane recep-
tors are restricted in two dimensions due to spatial limitations
imposed by the cell membrane. As a result, membrane-asso-
ciated events are governed by two-dimensional (2D) kinetics
and afﬁnity (8), where association rate (ka) and binding
afﬁnity (KA) constants are expressed inmm
2 s1 per molecule
and mm2 per molecule, respectively (because these constants
are proportional to the surface density commonlymeasured in
moleculesmm2), instead of the traditional three-dimensional
(3D) chemistry that occurs between solublemolecules, with ka
in M1 s1 and KA in M
1. The calculation of 2D binding
parameters offers a means to understand better the binding
mechanisms of molecular interactions between apposed
membranes, because these parameters are related directly to
the function of membrane proteins (9–11).
The recent development of ﬂuorescence and mechanical
methods allowed a partial characterization of 2D membrane-
protein interactions. Fluorescence methods were used to
derive 2D binding afﬁnities during the application of recep-
tor-expressing cells on a glass-supported lipid bilayer re-
constituted with ﬂuorescently labeled ligands (9,11,12). The
equilibrium constants for cell adhesion molecule CD2 and its
ligands (9,11,12) CD48 and CD58, and for cell adhesion
molecule CD28 and its ligand (13) CD80, were derived by
ﬂuorescence methods. Mechanical methods, such as the ﬂow
chamber assay (3,4,14), the micropipette method (15,16), and
the centrifugation method (17), are based on the fact that two
surfaces (e.g., cell-cell or cell-substrate) are cross-linked
through the formation of receptor-ligand bonds. These tech-
niques allow for the determination of 2D dissociation rate
constants from measurements of the lifetime of single mole-
cule-mediated adhesion. The dissociation rate constants for the
ligand binding of L-selectin and P-selectin are among the pa-
rameters that were calculated by such methods (4,10). A
combination of these methods could provide both 2D afﬁnity
and kinetics data. However, such an approach would be labor-
intensive and not suitable for the development of fast or high-
throughput assays. As a result, the development of tools for the
real-time analysis of cell-bound interactions would be signiﬁ-
cant for both basic and applied research.
Biosensors are analytical devices that offer rapid detection
of biological interactions occurring between surface-bound
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molecules and their water-soluble or dispersed analytes. They
can also provide detailed information about binding afﬁnity
and, often, the kinetics of binding. Mass-related, label-free
transduction technologies based on optical and acoustic waves
were used extensively for the study of various interactions, i.e.,
antibody/antigen, protein/peptide, DNA/protein, and DNA/
DNA (18,19). Despite the wide use of direct biosensors with
soluble analytes, limited data exist on the detection of whole
cells and cell-bound membrane-receptor interactions (20).
Surface plasmon resonance (SPR) devices were successful in
the detection of red blood cell-ligand interactions because of
the deformable disk morphology of red blood cells, which
facilitates coverage of the sensor surface (21,22). However,
optical biosensors are less effective with spherical cells,
probably because of the relatively large cell mass present in the
;300-nm evanescent ﬁeld, which produces a bulk response
overshadowing the underlying mechanisms related to the for-
mation of membrane receptor/ligand bonds (20).
Acoustic biosensors have the potential to study cell/sub-
strate binding events because they are sensitive not only to
mass coupling, but also to viscoelastic changes occurring
close to the sensor surface (23). Studies based on a quartz-
crystal microbalance device were used for monitoring mac-
roscopic dynamic processes occurring close to the sensor
surface. Such studies provided important information about
different molecular mechanisms responsible for cell attach-
ment, adhesion, spreading, and cytoskeleton rearrangement
(24–26). However, these studies were all qualitative, and, to
our knowledge, full characterization of cell-surface interac-
tions has not been realized.
In this work, a shear acoustic-wave biosensor, based on a
Love waveguide conﬁguration, was used to monitor the
binding of receptor-bearing cells, i.e., B-lymphoblastoid LG2
cells expressing class I major histocompatibility complex
(MHC) molecules, to a speciﬁc monoclonal antibody immo-
bilized on the sensor surface. Acoustic energy dissipation,
detected as a function of time upon the addition of viable cells
to a modiﬁed sensor surface, was found to correlate directly
with the number of cell-membrane receptors speciﬁcally at-
tached to immobilized antibodies. This ﬁnding, together with a
detailed mathematical analysis of the binding, allowed for the
kinetic and physicochemical characterization of interactions
leading to the calculation of 2D kinetic and afﬁnity parameters.
EXPERIMENTAL SECTION
Cell cultures and treatments
The Epstein-Barr virus-transformed human B-lymphoblastoid cell line LG2
(HLA-A*02011/1, kindly provided by H. Reyburn, Department of Pathology,
University of Cambridge, Cambridge, UK) and chronic myelogenous leukemic
K562 cells (HLA-ABC, a generous gift of S. Perez, Center for Cancer
Immunology and Immunotherapy, St. Savvas Hospital, Athens, Greece) were
used in this work. RPMI-1640 (Invitrogen, Carlsbad, CA), supplemented with
1 mg L1 gentamycin and 10% fetal bovine serum, was used as culture me-
dium. Culture ﬂasks were kept in a humidiﬁed 5% CO2 atmosphere at 37C.
The medium was exchanged every 2–3 days. Cell density was 3–83 105 cells
mL1 in normal cultures, and 2–3 3 106 cells mL1 in high-density cultures.
Viability was checked before experiments by the trypan blue exclusion tech-
nique, and cell number was counted on a Neubauer slide. Dead cells never
constituted over 5% of the total. Cells were washed with phosphate-buffered
saline (PBS) (Sigma, St. Louis, MO), centrifuged at 2503 g and resuspended
in PBS before addition to the sensor surface. To remove cell-surface HLA-A2-
associated peptides, LG2 cells were brieﬂy (90 s) treated with ice-cold citric
acid-Na2HPO4 buffer at pH 3.2 (27) (a mixture of an equal volume of 0.263 M
citric acid and 0.123 M Na2HPO4), and then washed with PBS.
Flow cytometry
For measuring the number of cell-surface HLA-A2 molecules, cells were
incubated with the anti-HLA-A2 monoclonal antibody BB7.2 (Becton
Dickinson, Franklin Lakes, NJ) and ﬂuorescein isothiocyanate-conjugated
anti-mouse IgG secondary ﬂuorescence-activated cell sorter antibody (Dako,
Glostrup, Denmark), both at saturating conditions. Samples were analyzed in
a ﬂuorescence-activated cell sorter (FACS) scanner (FACS Culiber, Becton
Dickinson). Light-scattering and ﬂuorescein isothiocyanate ﬂuorescence data
were collected on four-decade logarithmic scales. We used QIFIKIT (Dako)
to perform a quantitative immunoﬂuorescence indirect assay, using different
populations of plastic beads with a known speciﬁc number of attachedmouse
immunoglobulin G (IgG) molecules. The number of cell-surface HLA-A2
molecules was calculated according to the manufacturer’s instructions.
Acoustic device setup
The 110-MHz quartz devices were fabricated in-house on 0.5-mm-thick
Y-cut piezoelectric quartz crystals. The interdigitated transducers, composed
of a 210-nm-thick Cr/Au (10/200 nm) electrode, consisted of 80 pairs of split
ﬁngers, with a periodicity of 45mm. The devices were coated with a 0.7-mm-
thick poly(methylmethacrylate) (Aldrich, St. Louis, MO) layer, on top of
which 20 nm of gold were sputtered, using a BAL-TEC SCD 050 sputter
coater (BAL-TEC AG, Balzers, Liechtenstein). The acoustic devices were
mounted on a special holder, and liquid was pumped through on the area
between interdigitated transducers (IDTs), using a peristaltic pump (Gilson,
Middleton, WI) and a ﬂow-through cell. The ﬂow cell was sealed on the
surface by using a custom-made rubber gasket, exposing a sensing area of 12
mm2. AHewlett-Packard (Palo Alto, CA) 4195A network analyzer was used
to monitor the amplitude and phase of the wave, and LabVIEW (National
Instruments, Austin, TX) software was used for collecting acoustic data.
Preparation of biosensor surfaces and acoustic
cell detection
Freshly plasma-etched gold surfaces were incubated with a protein G (Cal-
biochem, SanDiego, CA) solution (1mgmL1) that was left to adsorb for 1 h
at room temperature. After protein adsorption, the devices were inserted in
the device holder, washed, and left to equilibrate with PBS (Sigma) at a ﬂow
rate of 50 mL min1. Antibody solutions of 0.1, 0.5, 1, or 10 mg mL1 were
pumped over the biosensor surfaces at a 25-mL min1 ﬂow rate, and the
interaction with gold-adsorbed protein G was monitored in real time. The
IgG surface densities were measured with SPR (SR7000, Reichert Analytical
Instruments, Depew, NY) by injecting the antibody over a protein G-mod-
iﬁed sensor surface. Acoustic experiments with cell suspensions involved the
addition of cell suspensions with cell numbers ranging from 6.0 3 104 to
6.0 3 105 cells mL1 on the device surface, at a ﬂow rate of 10 mL min1.
Experiments were run at least in triplicate. Real-time acoustic data were
analyzed using Microcal (Northampton, MA) Origin 6.1 software.
Image acquisition
After an acoustic experiment, the biosensor surface was observed under
a Nikon (Tokyo, Japan) Eclipse E800 microscope, and photographs were
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taken with an attached Nikon Coolpix E5400 camera. Because the sensor
chip is not opaque, no ﬂuorescent staining was needed for the observation of
cells. Image analysis was performed using Adobe Photoshop software. Cells
on the sensor surface were counted in at least three different areas.
RESULTS AND DISCUSSION
Love-wave device and receptor/ligand pair
The acoustic waveguide device (Fig. 1), operating at 110
MHz, was described elsewhere (28–32). Brieﬂy, the appa-
ratus comprises a quartz-crystal device that uses a set of IDTs
to generate and detect a shear-horizontal surface acoustic
wave. The phase and amplitude of the wave, which are re-
lated to acoustic velocity and energy, respectively, are mea-
sured as a function of time through electrical connections to
the IDTs. A polymer layer, deposited on the device surface,
serves as an acoustic waveguide by localizing the acoustic
energy of the wave close to the sensing surface. An additional
gold layer, deposited on top of the polymer, serves as a
surface that allows immobilization of the biorecognition
layer. All sensing occurs only within the liquid layer in
contact with the device surface, in which there is signiﬁcant
displacement as a result of acoustic wave/liquid coupling.
The thickness of this layer, deﬁned as the penetration depth
(23) d of the sensor, is a feature of the operating frequency f
and interface viscosity h; according to d ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃhr=2pfp : The
penetration depth of the 110-MHz sensor used in this study is
calculated at 50 nm for pure water. In practice, calculating the
exact viscosity of an interface layer when cells are bound to
the device surface is not easy. However, indirect evidence
suggests that the sensor’s response during cell-binding is
similar to that obtained when the device is loaded with 16%
glucerol, corresponding to a penetration depth of ;100 nm.
The device was used to detect interactions between re-
ceptors attached to whole cells and antibodies immobilized
on the sensor surface (Fig. 2). The membrane receptor used
was the HLA-A2 molecule, the most common class I MHC
allele in human populations, expressed in the B-lympho-
blastoid LG2 cell line. The natural function of HLA-A2 is to
present short, endogenous peptides (8–11 residues) to the
T-cell receptors of T lymphocytes, which can trigger an im-
mune response (33). The surface-immobilized ligand was the
anti-HLA-A2 monoclonal antibody BB7.2. Oriented immo-
bilization of the antibody through the Fc fragment (31,34)
was achieved by applying anti-HLA-A2 antibody to a protein
G-coated device surface. The antibody is speciﬁc for the
a chain (35) of HLA-A2 when the latter exists in a hetero-
trimer form consisting of a chain/b2-microglobulin/peptide
(36). Apart from the heterotrimeric form, HLA-A2molecules
on the cell membrane can be found in a heterodimeric form,
i.e., simply as a-chain/b2-microglobulin, or as single a-chains
(37); a-chains in the last two forms are not recognized by
BB7.2. The number of HLA-A2 heterotrimers present on the
cell membrane was controlled by using LG2 cells prepared
under three different conditions: as untreated cells, as mild
acid-treated, and as untreated from high-density cultures.
Mild acid treatment removes bound peptides from the HLA
groove (27), so that treated cells have low heterotrimer
numbers. In addition, cells grown in high-density cultures
will display high heterotrimer numbers on the cell surface
(37). Using an indirect quantitative immunoﬂuorescence
assay and ﬂow cytometry, the number of HLA-A2 hetero-
trimers (also referred to here as HLA) on the cell surface was
calculated. The values were: 3.7–5.7 3 105 HLA-A2 mole-
cules per untreated LG2 cell (12 experiments), 1–10 3 104
HLA-A2 molecules per mild acid-treated LG2 cell (6 ex-
periments), and 9.7–10.03 105 HLA-A2 per LG2 cell from a
high-density culture (4 experiments).
Acoustic signal-damping as a measure of
number of HLA/anti-HLA bonds
The Love-wave acoustic sensor is sensitive to mass-loading
and viscosity changes occurringwithin the sensor’s penetration
depth (23). Mass changes because of the deposition of a rigid
ﬁlmwill only affect the phase or frequency. Energy dissipation,
measured here as amplitude change, will only be affected by
viscosity/viscoelastic changes (23). Previous studies using
shear acoustic-wave devices showed that dissipation is more
sensitive to cell adhesion than phase or frequency/phase as a
result of severe damping of the acoustic wave by the presence
of viscoelastic cells (26,38). Here, the addition of LG2 cells to
the modiﬁed biosensor surface affected the amplitude signal
signiﬁcantly and in proportion to the concentration of the in-
jected cell suspension, i.e., cells mL1 (see Fig. 6 a). In con-
trast, the phase signal could not discriminate between samples
containing different number of cells (data not shown).
In addition, it was shown that the acoustic signal is mostly
sensitive to speciﬁc cell/surface contacts, whereas the presence
of the cell alone in the vicinity of the sensor surface is not
sufﬁcient to produce a signal change (24,39,40). To investigate
further whether the signal change reﬂects the formation of
cell-bound HLA/anti-HLA-A2 complexes, experiments were
performed using cells with different numbers of HLA-A2
FIGURE 1 Schematic representation of acoustic Love-wave biosensor.
Surface of quartz-based acoustic-wave device, where two IDTs are depos-
ited, is covered with a thick polymer guiding layer. A thin layer of gold is
deposited on top of the poly(methylmethacrylate) (PMMA) and between
IDTs.
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receptors on their surface. For this reason, the three different
types of LG2 cells, i.e., untreated, treated with a mild acid, and
from high-density cultures, were injected under ﬂow (10 mL
min1) at various concentrations on the antibody-modiﬁed
surface. Parallel microscopic and acoustic monitoring of the
number of bound cells and amplitude change, respectively,
revealed that, for the same number of bound cells, the
acoustic-signal change depended on the number of HLA-A2
molecules present on the cell membrane. This was clearly
shown by plotting amplitude changes versus total number of
HLA-A2 molecules available for binding on the sensor sur-
face (Fig. 3); the number of HLA molecules was derived by
multiplying the number of cells on the sensor surface at
equilibrium by the corresponding number of HLA hetero-
trimers (determined by FACS). Fig. 3 proves that the for-
mation of speciﬁc HLA/anti-HLA bonds is the major cause of
the acoustic response, and not the immobilization of cells on
the sensor surface per se.
A physical explanation of these observations can be de-
rived by looking at the sensor/cell interface (Fig. 2). Close
inspection of the geometry of the biological sensing layer
reveals that protein G would form a 5–10-nm-thick layer,
whereas the IgG layer is extended further, for another 15-nm
maximum (41). Upon cell addition, the HLA molecules at-
tached to the 6–10-nm-thick cell membrane would interact
with the immobilized IgG through the 7-nm-long extracel-
lular part of HLA-A2molecules (33). Taking into account the
sensor’s penetration depth (;100 nm), it is clear that the vast
majority of the cell mass (cell diameter, 14.46 2.2 mm) will
be outside the device’s sensing volume. Our results suggest
that the total mass of the HLA-A2 receptors bound to surface-
immobilized antibodies is too low to cause a phase change
that can be directly correlated to mass coupling. Instead, the
amplitude response, which is related to acoustic energy dis-
sipated from the sensor surface to the liquid interface, shows
remarkable sensitivity. Apparently the cell membrane, in
which HLA molecules are embedded, acts as an effective
damper by absorbing energy through the HLA-A2/antibody
bonds, and hence the observed amplitude change occurs.
The speciﬁcity of binding was assessed with acoustic ex-
periments recording amplitude change during the addition
of 2.5 3 105 cells/mL to the device surface. Cell samples
included untreated K562 cells (which do not express any
HLA-A2), untreated LG2 cells, and anti-HLA pretreated LG2
cells on the antibody-modiﬁed surface, as well as untreated
LG2 cells on biosensor surfaces lacking the anti-HLA anti-
body, i.e., with just protein G. The LG2 cells pretreated with
anti-HLA antibody showed lower binding than the untreated
ones, because fewer HLA heterotrimers were available to bind
to the immobilized antibody. Finally, negligible binding of
LG2 cells to the protein G-modiﬁed surface was detected.
These experiments proved the speciﬁcity of the observed sig-
nal change to the formation of HLA/anti-HLA bonds (Fig. 4).
Real-time acoustic experiments with cell
suspensions under ﬂow
The interactions of cell-membrane molecules with surface-
immobilized ligands may not be affected solely by molecular
kinetics and afﬁnity if the binding takes place under an
externally applied mechanical force (42) inducing high shear
stresses, as is the case with mechanical methods used for
determining 2D dissociation rate constants (3,4,14). Under
conditions of ﬂow, a critical number of cell-membrane re-
ceptor/immobilized ligand bonds must be formed for the at-
tachment of a single cell (43,44). In this study, we wanted to
FIGURE 2 Schematic representation
of biorecognition layer. Cells are at-
tached to surface via speciﬁc bonds
formed between cell-bound HLA-A2
molecules and surface-immobilized anti-
HLA antibody. Dashed line indicates
approximate area inside which the Love-
wave acoustic biosensor is sensitive to
interfacial changes (image not drawn to
scale).
FIGURE 3 Amplitude-signal changes plotted against number of total
membrane HLA-A2 molecules on sensor surface for three types of LG2 cells
(untreated, high-density cultures, and mild acid-treated).
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minimize the effect of external mechanical forces applied on
cells, i.e., the shear stress, and only probe the molecular ki-
netics and afﬁnity. Therefore, low ﬂow rates were used so
that the shear stress applied to cells inside the ﬂow cell
(31,45) (3.9 3 103 dynes cm2) would not induce cell de-
tachment after initial tethering (4). The ﬂow rate of 10 mL
min1 was selected for all experiments, because it yielded the
highest acoustic signal change on addition of 2.53 105 cells
mL1, indicating efﬁcient cell transfer to the biosensor sur-
face and the development of a sufﬁcient number of stable
HLA/anti-HLA bonds, leading to cell attachment.
In addition, a relatively high surface density (5.9 6 1.9 3
103 molecules mm2) was used for the immobilized anti-
HLA-A2, to facilitate cell attachment. Three lower surface
densities were also applied (Table 1). It was found that the
number of LG2 cells attached on the sensor surface per unit
area is minimally affected by even a ﬁvefold decrease in anti-
HLA surface density. It should be also noted that the off-rate
(2.90 3 104 s1) of the interaction between protein G and
mouse monoclonal antibodies (31) is slower than the 30 min
during which the signal of cell binding is monitored and used
for kinetics. Thus, the higher anti-HLA surface density was
selected for all acoustic experiments, because it also offered
better reproducibility of the acoustic signal.
Fig. 5 shows a typical response of the acoustic-signal
amplitude change as a function of time. After harvesting,
LG2 cells in PBS were injected over the antibody-function-
alized sensor surface under ﬂow (10 mL min1). Before and
after the injection of cells, the acoustic signal was equili-
brated with PBS as running buffer, at a ﬂow rate of 50 mL
min1. Furthermore, to minimize any interference from cell
diffusion-limited kinetics, only that part of the graph that
ﬁtted well (95%) to a single exponential curve, assuming a
one-to-one reaction, was applied to our calculations (46),
whereas the ﬁrst 500 s after the addition of cells were not
included in the kinetic analysis. Cells come into contact with
the sensor surface via their microvilli, and initial contacts are
formed between surface-immobilized IgG and HLA mole-
cules at the tips of the microvilli. Cells, in general, spread
isotropically in the absence of serum proteins (47), and at
high densities of immobilized ligand (48). Thus, LG2 cells
will form a large, circular contact area during the ﬁrst minutes
of interaction (49). This contact area will be discontinuous,
and will be formed by spatially separated point contacts
(microvilli). After this initial phase (ﬁrst 500 s), the signal
changes observed should mainly reﬂect the formation of new
HLA/antibody bonds as a result of the spreading of microvilli
and HLA-A2 lateral diffusion in the cell-surface contact area.
Over time, the microvilli will spread to form a ﬂat contact
area (8,11). The time required for cells to reach equilibrium
was 62 6 18 min (25 experiments from eight different
concentrations). Microscopy photographs revealed that, at
equilibrium, LG2 cells retain their round shape on the bio-
sensor surface and display limited spreading, mediated by
short ﬁlopodia (Fig. 5, inset).
2D kinetic analysis of cell-bound
HLA-A2/anti-HLA interaction
The amplitude signal change is a measure for the formation
of HLA-IgG bonds. Thus, kinetic information can be calcu-
lated from the real-time binding curves for cell-bound HLA/
immobilized anti-HLA interactions. Experiments were per-
formed with cell suspensions containing different numbers of
untreated LG2 cells (Fig. 6 a). For kinetic calculations, the
analysis described for 3D interactions (31,50) was applied
according to the equation
DðdA=dtÞ=DA ¼ ka C1 kd; (1)
where D(dA/dt) and DA represent the change in rate and
overall amplitude, respectively, derived from real-time
graphs, C represents the concentration of soluble analyte,
and ka and kd represent the association and dissociation rate
FIGURE 4 Speciﬁcity of cell binding assessed with amplitude signal
change during addition of 2.5 3 105 cells mL1 to the device surface. Cell
samples included untreated K562 cells (which do not express any HLA-A2)
on anti-HLA modiﬁed device surfaces, untreated LG2 cells on biosensor
surfaces lacking the anti-HLA antibody, and anti-HLA pretreated and
untreated LG2 cells on antibody-modiﬁed surfaces.
TABLE 1 Effect of surface concentration of anti-HLA
monoclonal antibody on acoustic signal amplitude change and
number of bound cells during application of 2.53 105 cells mL1
Anti-HLA
concentration
(mg mL1)
Anti-HLA surface
density (molecules
mm2)*
Amplitude change
(dB) for 2.5 3 105
cells mL1
LG2 cells attached
on sensor surface
per mm2y
0.1 88 0.06 13
0.5 572 0.29 257
1.0 1181 0.84 1236
10.0 5858 0.99 1287
*Values obtained from surface plasmon resonance.
yCells on sensor surface were counted under microscope from at least three
different areas.
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constants, respectively. In our case, the 3D molar concentra-
tion C was replaced by the 2D HLA-A2 surface density C2D,
which should reﬂect the number of cell-membrane HLA
molecules available for binding, and ka and kd are the
corresponding 2D rate constants.
For determiningC2D, two parameters are of interest: 1), the
total number of laterally mobile HLAmolecules available for
interaction on each cell surface, i.e., [HLA] and 2), the total
number of bound cells or % surface coverage by cells. The
number of laterally mobile HLA molecules available for in-
teractions on each cell surface is given as (12)
½HLA ¼ NHLA3 ðf =ScellÞ: (2)
NHLA is the total number of HLA molecules on the cell
surface, f is their fractional mobility, and Scell is the cell
surface. The surface area (Scell) of cells was calculated at
633.15 mm2 (Scell ¼ pd2, where the cell’s diameter d was
measured from microscopy photos at 14.4 mm). To account
for the irregularities of the cell membrane (12), Scell was
multiplied by a surface roughness factor of 1.8, resulting in a
ﬁnal value of 1172.6 mm2. Based on the average number of
4.7 3 105 HLA-A2 receptors per untreated cell and the
receptors’ fractional mobility (51) f of 93.5%, [HLA] was
calculated at 374 6 80 molecules mm2. Because the
experiments were run in the absence of culture medium and
serum, we assume that there was no net change in the number
FIGURE 5 Amplitude change as a function of time
during interaction of LG2 cells (2.5 3 105 cells mL1)
with surface-immobilized anti-HLA antibody. Arrows
(a and b) indicate corresponding times for addition of cell
suspension and buffer, respectively. The binding curve is
divided into two phases. The ﬁrst (;500 s after addition)
represents time required for cells to reach the surface and
form initial tethers, and is cell-diffusion limited. The second
phase (colored rectangle) depicts formation of HLA/anti-
HLA bonds. (Inset) Microscopy photograph of LG2 cells
on biosensor surface after an acoustic experiment. Scale
bar, 15 mm.
FIGURE 6 Kinetic analysis of cell-bound HLA/anti-HLA interaction. (a) Real-time binding curves when various LG2 cell suspensions were added over
immobilized anti–HLA antibody. Arrows (t0 and t1) indicate times for addition of cell suspension and buffer, respectively. Cell suspensions: 6.03 10
4/mL (h),
1.23 105/mL (D), 1.53 105/mL (d), 2.43 105/mL (n), 3.03 105/mL (s), and 6.03 105/mL (:). Note that only data used in the kinetic analysis are shown.
(b) Schematic representation of sensor surface at full cell coverage Ccellsfull : (c) Plot of D(dA/dt)/DA (where (dA/dt) and DA are the rate and corresponding
amplitude change derived from real-time curves, and D(dA/dt)/DA is the slope of (dA/dt) against DA) versus effective [HLA], i.e., C2D, as calculated from Eq. 4.
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of HLA molecules on the cell surface, and also that the
overall cell surface remained constant. Therefore, [HLA] was
considered constant throughout the experiments.
The second parameter of interest was the % surface cov-
erage by cells. In our experiments, the total number of HLA
receptors per cell remained constant, and the only variable
was the number of applied cells. This implies that 374 mol-
ecules mm2 is the maximum [HLA] that can be presented to
the sensor’s surface and will correspond to the ideal case of
complete coverage of the surface by cells, resulting in an
almost ﬂat membrane ﬁlm apposed to the sensor’s surface
(Fig. 6 b). If Ccellsfull is the cell suspension at which full surface
coverage is observed, then for cell suspensions lower than
Ccellsfull ; the HLA surface density per cell will still remain 374
molecules mm2. However, the effective [HLA] sensed by
the sensor will be a function of the coverage of the sensor
surface by the cells, i.e., of dcellsi =d
cells
full ; where d is the cells’
surface density on the device. The observed linear relation-
ship between Ccells and dcells up to the saturation level allows
rewriting the above ratio as Ccellsi =C
cells
full :
Given the above analysis,C2D, which is the effective [HLA]
sensed by the sensor and, thus, the equivalent to the soluble
analyte concentration used in Eq. 1, can be calculated as
C
2D ¼ ½HLA3Ccellsi =Ccellsfull : (3)
In our experiments, maximum cell coverage was observed
at cell suspensions equal to or higher than Ccellsmax ¼ 6 3 105
cells mL1, as detected acoustically through DA measure-
ments. Microscopy photographs, obtained in parallel, re-
vealed that the corresponding dcells (2603 cells mm2) was
not equal to dcellsfull but, in fact, corresponded to a surface
coverage of 42.4% (Based on microscopy photos, after the
experiments with cell suspensions of 6 3 105 cells mL1 or
higher, the observed maximum number of cells on the sensor
surface was 31,236 cells. Taking into account the cell’s
maximum contact area (162.9 mm2) and the sensor surface
(12 mm2), the observed maximum coverage was calculated
from the ratio of the total area covered by the cells versus the
sensor surface, and was 42.4%.) This correction factor was
ﬁnally taken into account when calculating C2D. Therefore,
Eq. 3 becomes
C
2D ¼ 3743 0:4243Ccellsi =Ccellsfull ¼ 158:63Ccellsi =Ccellsfull :
(4)
Plotting D(dA/dt)/DA (Eq. 1) versus C2D (Eq. 4) allows for
the measurement of the 2D association and dissociation rate
constants: ka from the slope and kd from the intercept with the
ordinate are calculated to be 1.15 3 105 mm2 s1 per
molecule and 2.07 3 105 s1, respectively (Fig. 6 c). The
2D binding afﬁnity KA is then calculated as KA ¼ ka/kd ¼
0.556 mm2 per molecule.
The above analysis was performed given a constant sur-
face density for immobilized IgG. Although dissociation was
not observed for whole cells, it can occur for single HLA/
anti-HLA bonds. Rebinding of dissociated HLA can readily
occur, given the relatively high surface antibody density
(5.9 6 1.9 3 103 molecules mm2). Moreover, the lateral
diffusion of HLA molecules on the membrane of B-lym-
phoblastoid cells was higher (51) (1.75 3 101 mm2 s1)
than the measured association rate constant for bond forma-
tion (1.153 105 mm2 s1). Hence the rate constant was the
limiting step, and was therefore what was measured.
It is worth mentioning that the 2D binding parameters are
not absolute. Afﬁnity in two dimensions depends on the local
microtopological conditions of the cell-substrate or cell-cell
contacts (8,52). Molecular motion, membrane stiffness, cy-
toskeleton condition, and molecule segregation by size can
all have an important effect on 2D interactions. In our case,
the binding kinetics should also depend on the kinetics of
membrane bending during the microvilli spreading process.
Further experiments, e.g., with cytoskeleton tampering
drugs, would shed more light on the individual contributions
of each parameter.
Other 2D afﬁnities were calculated using ﬂuorescence
methods (9,11,12) for interactions of the cell-adhesion mol-
ecule CD2 with its ligands, CD58 (KA ¼ 0.13 mm2 per
molecule) and CD48 (KA ¼ 0.02 mm2 per molecule), at-
tached to a planar lipid bilayer. For cell membrane-molecule
interactions, there is a linear correlation between 3D and 2D
binding afﬁnities (8,53). The 2D afﬁnities measured in the
above systems are related to their low 3D afﬁnities (5 3 105
M1 and 4 3 104 M1, respectively). In our case, the 3D
afﬁnity was expected to be on the order of 108 M1 (as an
antibody/antigen interaction). Therefore, a higher 2D binding
afﬁnity was measured (0.556 mm2 per molecule).
CONCLUSIONS
We have developed what we consider a new and simple ap-
proach for detecting and characterizing whole-cell receptors
interacting with surface-immobilized ligands. The acoustic
signal used here, together with a modiﬁed 3D kinetic analysis,
measured detailed 2D kinetics and derived both association
and dissociation rate constants, as well as the afﬁnity of cell-
membrane protein binding events. Attempts to repeat this
work with an SPR device were not successful. The change in
refractive index observed upon cell addition was indiscrimi-
nate of speciﬁc or nonspeciﬁc binding, conﬁrming that SPR
gives a bulk response based on the cell mass present in the
evanescent ﬁeld, rather than on the number of speciﬁc cell/
surface bonds. In contrast, the sensitivity of acoustic damping
to the number of cell/surface speciﬁc bonds provides a unique
sensing mechanism for investigating membrane interactions.
Clearly, the proposed label-free and noninvasive acoustic
biosensor could be applied further to characterize various
membrane-associated events. Potential systems for study in-
clude T-cell receptor/MHC and MHC/antigenic peptide in-
teractions using whole cells, without the need for membrane
protein puriﬁcation or reconstitution. Moreover, the technique
resembles currently applied ﬂuorescence methods, because it
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measures unstressed molecular afﬁnities between cell and
substrate, while offering the advantage of yielding both ki-
netics and afﬁnity constants without the need for labels. Using
kinetic parameters for the calculation of 2D afﬁnity constants
also omits the need to measure contact areas between cell and
substrate. Further advances in microﬂuidics will allow for the
development of acoustic arrays that could facilitate drug
screening during the simultaneous testing of large numbers of
membrane-active compounds.
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